Characteristics of Gorilla-Specific Lactobacillus Isolated from Captive and Wild Gorillas
by
,
Sayaka Tsuchida
1,2
,
Steven Kakooza
3,4,
Pierre Philippe Mbehang Nguema
5,
Eddie M. Wampande
3 and
Kazunari Ushida
1,2,* 1
Academy of Emerging Sciences, Chubu University, 1200 Matsumoto-cho, Kasugai-shi, Aichi 487-8501, Japan
2
Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Shimogamo, Kyoto 606-8522, Japan
3
Central Diagnostic Laboratory, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, P.O. Box 7062 Kampala, Uganda
4
Novel Minds Science Plexus, P.O. Box 7062 Kampala, Uganda
5
Research Institute of Tropical Ecology, BP 13354 Libreville, Gabon
*
Author to whom correspondence should be addressed.
Microorganisms 2018, 6(3), 86; https://doi.org/10.3390/microorganisms6030086
Submission received: 30 June 2018
/
Revised: 11 August 2018
/
Accepted: 14 August 2018
/
Published: 14 August 2018
(This article belongs to the Special Issue Wildlife Microbiology)
Abstract
:Lactic acid bacteria (LAB) reside in a wide range of mammals, such as autochthonous intestinal bacteria. In this paper, we present the phenotypic and phylogenetic characteristics of gorilla-specific LAB. Lactobacillus gorillae—previously isolated from the wild and captive western lowland gorillas (Gorilla gorilla gorilla)—were successfully isolated from wild mountain gorillas (Gorilla gorilla beringei) in addition to other captive and wild western lowland gorillas. The strains from wild gorillas could ferment D-xylose, arbutine, cellobiose, and trehalose better than those from captive gorillas. By contrast, tolerance to NaCl was higher in isolates from captive gorillas than in those from wild gorillas. This tendency may have been induced by regular foods in zoos, which contain sufficient amount of salts but less amount of indigestible fiber and plant secondary metabolites compared to foods in the wild. All strains of L. gorillae showed inhibitory activities to enteric pathogenic bacteria; however, the activity was significantly higher for strains from wild gorillas than for those from captive gorillas. This may have been induced by the captive condition with routine veterinary intervention. Since L. gorillae can grow in the gastrointestinal tract of gorillas in captivity, the strains from wild mountain gorillas are potential probiotics for gorillas under captive conditions.
1. Introduction
The gastrointestinal tract (GIT) microbes of mammals develop complex ecosystems with a vast diversity after birth, which largely varies between animal species and individuals [1,2]. Accordingly, host species, particularly humans, are now recognized as being made up of superorganisms together with indigenous microbes [2,3,4]. Lactic acid bacteria (LAB), which are narrowly defined as bifidobacteria and lactobacilli, have been especially well studied because of their beneficial functions in humans. Many studies are concerned with the beneficial functions of LAB, for example, the immune-stimulating and modulation effect caused by the interaction between LAB and the intestinal mucosa of the host and its role in elevating the host’s defense against pathogenic penetration [5,6,7,8,9]. In addition, LAB are common members of the GIT microbes in a wide range of animals [10], and each animal species hosts autochthonous species of LAB in their GIT [11,12]. Some reports have described an essential role of diet in the development and maintenance of LAB in various animal hosts in captivity [11,13]; however, only few studies have revealed the composition of LAB in wild animals under wild feeding conditions. Specifically, the eating habits of herbivores and omnivores in the wild are quite different from those in captive conditions. Foods available in the wild habitats, particularly for herbivores, deploy several protective chemicals to escape from herbivory [14]. These plant secondary metabolites, particularly toxins, may negatively affect GIT microbes including LAB [15,16], but some GIT microbes can degrade these compounds to help the host to survive on such natural foods in the wild [17,18]. In our previous study, we demonstrated the efficient degradation of plant secondary metabolites and toxins by cecal bacteria in wild Japanese Rock ptarmigans (Lagopus muta japonica) [19,20].
In the present study, we have focused on Lactobacillus gorillae as a host-specific LAB, which has previously been proposed as a novel species of the genus Lactobacillus [21] and is considered as autochthonous LAB of gorillas. We have found that the phylogenetic relationship among strains of L. gorillae—isolated from various sources, such as captive and wild western lowland gorillas (Gorilla gorilla gorilla) and wild mountain gorillas (Gorilla gorilla beringei)—show the monophyly of isolates from G.g.b. isolates, apparently separated from those from captive and wild G.g.g. We have also shown the phenotypic characteristics and antimicrobial activities of various L. gorillae isolates and have demonstrated marked phenotypic differences between wild and captive G.g.g.
2. Materials and Methods
2.1. Bacterial Strains and Growth
The strains of L. gorillae used in the present study are shown in Table 1. Strains KZ01T, KZ02, KZ03, and GG02 were previously isolated from captive and wild western lowland gorillas [21]. Strains UM01, UM03, UR07, UR10, and UH14 were isolated from wild mountain gorillas in Bwindi Impenetrable National Park, Uganda; strains HZ04, HZ07, HZ10, HZ11, and HZ16 were isolated from captive western lowland gorillas in Higashiyama Zoo, Nagoya, Japan; and strains GG05, GG08, GG12, and GG15 were isolated from wild western lowland gorillas in Moukalaba-Doudou National Park, Gabon using a method described previously [22]. L. fermentum JCM 1173T, which is the closest neighbor to L. gorillae, was used as the control strain. Bacterial cultures were anaerobically grown on Lactobacilli MRS agar (BD Difco, Fisher Scientific, Ottawa, ON, Canada) at 37 °C for 48 h and stored at −80 °C as stock cultures for further analyses.
2.2. Phylogenic Analysis of 16S rRNA Gene
The partial 16S rRNA gene sequences were amplified as described previously [23]. These amplicons were sequenced at Hokkaido System Science Co., Ltd. (Sapporo, Japan) by dye-terminator method using ABI PRISM 3100 Genetic Analyzer (Applied Biosystems). Calculation of pairwise 16S rRNA gene sequence similarities was performed using MEGA version 7.0.20 [24]. Multiple sequence alignments were performed using the CLUSTAL W program [25], and phylogenetic trees were constructed using the neighbor-joining method [26] with Kimura’s two-parameter model [27] using MEGA version 7.0.20. Tree topology was evaluated by a bootstrap analysis with 1000 replicates using CLUSTAL W.
2.3. Phenotypic Characteristics
Biochemical characteristics were evaluated using API 50 CH and ZYM systems (bioMerieux, Marcy-l’Étoile, France) according to the manufacturer’s instructions. Tolerance to NaCl was examined in anaerobic MRS broth containing 6.5, 8.0, and 10% (w/v) NaCl. The positive or negative growth was determined by turbidity after 7 days at 37 °C incubation.
2.4. Antimicrobial Activity Assay
The agar well diffusion method as described by Onda et al. [28] was used with some minor modifications. In brief, the suspension of target enterohemorrhogic Escherichia coli (EHEC) adjusted to McFarland standard NO. 0.5 was inoculated on Muller Hinton agar (BD Difco) plates, and well holes were punched out of the agar using a cork borer. The wells were then filled with 75 µL of MRS culture supernatant of L. gorillae (adjusted to pH 7.0 by 0.1 N NaOH). The agar plates were aerobically incubated at 37 °C for 18 h. After incubation, the diameters (mm) of the inhibition zone were measured as antimicrobial activities. Comparison was made using Welch’s test in R (version 3.1.2) for the diameter of inhibition zone between strains from mountain gorillas in the wild (MW), those from western lowland gorillas in captivity (WC), and those from western lowland gorillas in the wild (WW).
The presently used EHEC (Strain Ehime) was kindly provided by Dr. Nobuo Nakanishi, KYODOKEN Institute (Fushimi, Kyoto 612-8073 Japan). The beta hemorrhagic strain was previously isolated from a piglet in a commercial pig farm in Ehime Prefecture, Japan, and characterized as Stx2e(+), AIDA1(+), and F18(+).
2.5. Antibiotic Resistance Profile
The 18 strains of L. gorillae were examined for their susceptibility to imipenem, cefotaxime, ofloxacin, amoxicillin, gentamicin, lincomycin, tetracycline, and erythromycin by the disk diffusion test.
The cells were grown on MRS agar under anaerobiosis at 37 °C for 18 h. A portion of colony was taken and suspended in Muller Hinton broth to McFarland standard NO. 0.5. Imipenem (10 µg/disk), cefotaxime (30 µg/disk), ofloxacin (5 µg/disk), amoxicillin (25 µg/disk), gentamicin (10 µg/disk), lincomycin (2 µg/disk), tetracycline (30 µg/disk), and erythromycin (15 µg/disk) disks were obtained from Eiken Chemical Co., Ltd. (Tochigi, Japan) and Nissui Pharmaceutical Co., Ltd. (Tokyo, Japan), and applied according to the manufacturer’s instructions. The inhibition zone was determined after 18 h of culture.
2.6. Ethics
Sampling of feces from gorillas was realized in a noninvasive manner under the supervision of either rangers, officers of the National Park, or officers of National Institutes in Uganda and Gabon. The research in Uganda was approved both by Uganda National Council for Science & Technology (UNCST) as NS540 (11 September 2015) and by Uganda Wildlife Authority (UWA) as EDO35-01 (11 August 2015). Research in Gabon was approved by Centre National de la Recherche Scientifique et Technique (CENAREST) as AR0033/11 (9 November 2011). Feces from captive gorillas were supplied by officers of the Kyoto City Zoo and the Higashiyama Zoo under the contract established between Kyoto Prefectural University and the director of both zoos.
3. Results
3.1. Phylogenetic Analysis of 16S rRNA Gene
According to 16S rRNA gene sequence phylogeny, strains of L. gorillae from western gorillas formed different monophyletic cluster from that of strains from mountain gorillas (Figure 1). The sequences of strains UR07 and UH14 showed the highest similarities to those of strain KZ01T, which is a type strain of L. gorillae, (99.8%) and to those of strain UM01, which presented with the lowest similarity to those of strain KZ01T (97.6%).
3.2. Phenotypic Characteristics
According to the API 50 CH and API ZYM results, all strains of L. gorillae possessed similar phenotypic traits as those of L. fermenum JCM 1173T, except for naphthol-AS-BI-phosphohydrolase, α-galactosidase, and α-glucosidase. Acid production from D-xylose, arbutin, esclin, salicin, cellobiose, lactose, trehalose, gluconate, and 2-keto-gulconate showed strain variations among the 18 strains of L. gorillae. In particular, acid was produced from 2-keto-gulconate by only the strains from mountain gorillas. For the enzyme activity pattern, cystine arylamidase was detected in only the strains from mountain gorillas (Table 1). None of the strains of L. gorillae could grow in MRS broth with the presence of 10% (w/v) NaCl, whereas all strains grew in the presence of 6.5% (w/v) NaCl. Only the strains from captive individuals (KZ01T, KZ02, and KZ03) grew in the presence of 8% (w/v) NaCl (Table 2).
3.3. Antimicrobial Activity Assay
All strains of L. gorillae inhibited the growth of EHEC to some extent. Antimicrobial activities determined as the inhibitory zone (mm) of all strains are shown in Figure 2. The inhibitory activities of strains from wild mountain gorillas (MW), wild western lowland gorillas (WW), and captive western lowland gorillas (WC) ranged from 11.68 to 13.74, 10.64 to 12.4, and 9.32 to 9.77, respectively. The inhibitory activities to EHEC were significantly higher for MW and WW than for those of WC (p < 0.01). However, no significant difference was observed in the inhibitory activities to EHEC between MW and WW (p = 0.072).
3.4. Antibiotic Resistance Profile
The antibiotic resistance profiles of L. gorillae are shown in Table 3. The disk diffusion test confirmed the resistance to cefotaxime for strains KZ02 and HZ11 from captive western lowland gorillas. Strains from captive western lowland gorillas KZ01T, HZ04, HZ07, and HZ10 also showed intermediate resistance to cefotaxime. Resistance to ofloxacin was confirmed in all strains from captive western lowland gorillas and wild mountain gorillas. None of strains tested showed resistance or intermediate resistance to imipenem, amoxicillin, gentamicin, lincomycin, tetracycline, and erythromycin according to the disk diffusion test.
4. Discussion
In the present study, we successfully isolated L. gorillae from the feces of captive and wild western lowland gorillas and wild mountain gorillas in addition to previously isolated L. gorillae. Since L. gorillae has been repeatedly isolated from western lowland and mountain gorilla, L. gorillae can be regarded as an autochthonous GIT microbe of the genus Gorilla. Interestingly, the phylogenetic analysis of 16S rRNA gene sequences revealed that L. gorillae formed two distinct phylogenetic clusters comprising either strains from western lowland gorillas or those from mountain gorillas (Figure 1). We hypothesized the divergence time of these two clusters of L. gorillae as 1.75 million years ago because the divergence time of western and eastern gorilla was estimated as 1.75 million years ago by whole genomic study of gorilla [29]. Based on our hypothesis on the divergence time of the two L. gorillae clusters, the divergence time of human-associated Lactobacillus (L. fermentum) and gorilla-specific Lactobacillus (L. gorillae) was calculated to be 8.3 million years old (Figure S1). L. fermentum is the phylogenetic neighbor of L. gorillae and can be regarded as human-associated LAB [30]. This divergence time for gorilla-specific LAB and its phylogenetic neighbor—a human-associated LAB—seems reasonable because the common ancestor of gorillas and humans existed until some 7–10 million years ago in the forest of Africa [29,31,32]. Thus, our hypothesis about the divergent time of 1.75 million years is plausible as the divergent time between the two groups of L. gorillae. Despite such an ancient phylogenetic separation, the strains from wild western lowland gorillas showed virtually the same phenotypic characteristics with those from wild mountain gorillas. A difference in 2-keto-gluconate utilization, the presence of cysteine arylamidase, and 66 other characteristics were found to be the same. However, the difference in phenotypic characteristics became more visible when the strains from wild gorillas were compared with those from captive gorillas. In fact, strains from wild gorillas, both western lowland and mountain gorillas, could utilize different types of sugars compared with strains from captive gorillas (Table 2). Considering the food composition of wild gorillas, the fermentation of D-xylose, cellobiose, and arbutin by gorilla-specific GIT microbes is important. D-xylose and cellobiose constitute hemicelluloses and cellulose of the plant cell wall, which are obviously rich in gorilla’s natural food items. Moreover, arbutin is a phenolic glycoside contained in wild fruits and leaves, which helps to avoid animal herbivory with its cytotoxicity [33]. The degradation of these plant secondary metabolites is an essential functionality of GIT bacteria in wild herbivore animals toward supporting the host-feeding behavior [17,19,20,34].
In addition to sugar utilization, tolerance to NaCl also showed interesting traits. All eight strains from captive gorillas showed higher tolerance to NaCl than those from wild gorillas. The food items in zoos contained sufficient, or sometimes excessive, amount of salts, whereas minerals, particularly sodium, were often depleted from the natural food items of wild gorillas. In fact, wild western lowland gorillas often consume unusual food items that are relatively rich in sodium, such as decayed wood bark or particular water plants [35,36]. Therefore, these differences in phenotypic characteristics between strains from wild and captive gorillas may have developed quite recently because the successful artificial feeding to the gorillas was recorded only in the mid-20th century. In fact, the first gorilla born under captivity was recorded in 1956 in USA. Selection by food items in captivity may have induced these phenotypic modifications. We have obtained the draft genome sequence of L. gorillae KZ 01T previously [37]. Since KZ 01T strain originated from a captive western lowland gorilla, further studies are needed to compare it with strains from wild gorillas in order to understand the genetic background of these phenotypic differences in the strains of L. gorillae.
According to the result of antimicrobial activity assay, all strains possessed the inhibitory activities to EHEC, and this activity was significantly higher for strains from wild gorillas than for those from captive gorillas (Figure 2). Therefore, it is suggested that L. gorillae produces some kind of bactericidal or bacteriostatic substances against enteric pathogenic bacteria, and strains from wild gorillas seem to be more health-promoting in terms of the prevention of enteric pathogenic infection. Veterinary intervention with drugs may have reduced the preventive effect of L. gorillae in captivity. Since the strains from wild mountain gorillas showed the highest activity, L. gorillae from wild mountain gorillas can be considered as the most beneficial strain for the health promotion of gorilla. Because L. gorillae can grow in the GIT of gorillas in captivity, the strains from wild mountain gorillas are considered good candidates for the probiotics under captive conditions. However, it was unexpected that the strains from mountain gorillas showed the same level of resistance to ofloxacin as the strains from the captive gorillas exhibited. Since the transferable antibiotic resistance in probiotic strains has become a serious safety concern [38], it is still advisable that analysis is carried out to understand the precise mechanisms of the drug resistance before direct feeding of these isolates is carried out on captive gorillas.
Supplementary Materials
The following are available online at https://www.mdpi.com/2076-2607/6/3/86/s1, Figure S1: Phylogenetic analysis using 16S rRNA gene by Neighbor-joining method (time-tree).
Author Contributions
Conceptualization, S.T. and K.U.; Methodology, S.T., S.K., P.P.M.N., E.M.W. and K.U.; Software, E.M.W.; Validation, S.T., and K.U.; Formal Analysis, S.T.; Investigation, S.T., and K.U.; Resources, S.T., S.K., P.P.M.N.; Data Curation, S.T.; Writing-Original Draft Preparation, S.T.; Writing-Review & Editing, E.M.W. and K.U.; Visualization, S.T.; Supervision, E.M.W. and K.U.; Project Administration, S.T.; Funding Acquisition, S.T. and K.U.
Funding
The study was supported by JSPS Grant-in-Aid for Young Scientist (B) Grant Number JP15K18775 and Grant-in-Aid for Scientific Research (B) JP25292165, and conducted as a part of the program ‘PROCOBHA’ supported by JST/JICA SATREPS.
Acknowledgments
The authors thank Masayuki Tanaka Ph D, Seitaro Wada DVM, Mitsunori Nagano (Kyoto City Zoo), and Yasuhiro Sato DVM (Higashiyama Zoo) for their help with collection fresh feces at the zoo. The authors also thank gorilla trackers and eco-guards in Moukalaba-Doudou National Park, Gabon, and Bwindi Impenetrable National Park, Uganda, for their help with collecting fresh feces. The authors give special thanks to Prof. J. D. Kabasa DVM Ph D, the Principal, College of Veterinary Medicine, Animal Resources and BioSecurity, Maerere University, Hellen N. Opolot and Isaac Makhuwa, Uganda National Council for Science and Technology, Alfred Ngomanda Ph D, The Director of Research Institute of Tropical Ecology, Gabon for their kind acceptance and helps to conduct this research.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Hooper, L.V. Bacterial contributions to mammalian gut development. Trends Microbiol. 2004, 12, 129–134. [Google Scholar] [CrossRef] [PubMed]
- Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T.; et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59–65. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hattori, M.; Taylor, T.D. The human intestinal microbiome: A new frontier of human biology. DNA Res. 2009, 16, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Lederberg, J. Infectious history. Science 2000, 288, 287–293. [Google Scholar] [CrossRef] [PubMed]
- Yamamoto, K.; Miwa, T.; Taniguchi, H.; Nagano, T.; Shimamura, K.; Tanaka, T.; Kumagai, H. Binding specificity of Lactobacillus to glycolipids. Biochem. Biophys. Res. Commun. 1996, 228, 148–152. [Google Scholar] [CrossRef] [PubMed]
- Kelly, D.; Conway, S.; Aminov, R. Commensal gut bacteria: Mechanisms of immune modulation. Trends Immunol. 2005, 26, 326–333. [Google Scholar] [CrossRef] [PubMed]
- Uchida, H.; Kinoshita, H.; Kawai, Y.; Kitazawa, H.; Miura, K.; Shiiba, K.; Horii, A.; Kimura, K.; Taketomo, N.; Oda, M.; et al. Lactobacilli binding human A-antigen expressed in intestinal mucosa. Res. Microbiol. 2006, 157, 659–665. [Google Scholar] [CrossRef] [PubMed]
- Fink, L.N.; Zeuthen, L.H.; Christensen, H.R.; Morandi, B.; Frøkiær, H.; Ferlazzo, G. Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses. Int. Immunol. 2007, 19, 1319–1327. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Riboulet-Bisson, E.; Sturme, M.H.; Jeffery, I.B.; O’Donnell, M.M.; Neville, B.A.; Forde, B.M.; Claesson, M.J.; Harris, H.; Gardiner, G.E.; Casey, P.G.; et al. Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota. PLoS ONE 2012, 7, e31113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mitsuoka, T.; Kaneuchi, C. Ecology of the bifidobacteria. Am. J. Clin. Nutr. 1977, 30, 1799–1810. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Endo, A.; Endo, F.Y.; Dicks, M.T.L. Diversity of Lactobacillus and Bifidobacterium in feces of herbivores, omnivores and carnivores. Anaerobe 2010, 16, 590–596. [Google Scholar] [CrossRef] [PubMed]
- Lamendella, R.; Santo Domingo, J.W.; Kelty, C.; Oerther, D.B. Bifidobacteria in feces and environmental waters. Appl. Environ. Microbiol. 2008, 73, 575–584. [Google Scholar] [CrossRef] [PubMed]
- Ley, R.E.; Hamady, M.; Lozupone, C.; Turnbaugh, P.J.; Ramey, R.R.; Bircher, J.S.; Schlegel, M.L.; Tucker, T.A.; Schrenzel, M.D.; Knight, R.; et al. Evolution of mammals and their gut microbes. Science 2008, 320, 1647–1651. [Google Scholar] [CrossRef] [PubMed]
- Bryant, J.P.; Reichatdt, P.B.; Clausen, T.P.; Provenza, F.D.; Kuropat, P.J. Woody plant–mammal interactions. In Ecological and Evolutionary Processes; Rosenthal, G.A., Berenbaum, M.R., Eds.; Elsevier: London, UK, 1992; pp. 343–370. [Google Scholar]
- Wallace, R.J. Antimicrobial properties of plant secondary metabolites. Proc. Nutr. Soc. 2004, 63, 621–629. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Uhlik, O.I.; Musilova, L.; Ridl, J.; Hroudova, M.; Vlcek, C.; Koubek, J.; Holeckova, M.; Mackova, M.; Macek, T. Plant secondary metabolite-induced shifts in bacterial community structure and degradative ability in contaminated soil. Appl. Microbiol. Biotechnol. 2013, 97, 9245–9256. [Google Scholar] [CrossRef] [PubMed]
- Allison, M.J.; Mayberry, W.R.; McSweeney, C.S.; Stahl, D.A. Synergistes jonesii, gen. nov., sp. nov.: A rumen bacterium that degrades toxic pyridinediols. Syst. Appl. Microbiol. 1992, 15, 522–529. [Google Scholar] [CrossRef]
- Osawa, R.; Walsh, P.T.; Cork, J.S. Metabolism of tannin-protein complex by facultatively anaerobic bacteria isolated from koala feces. Biodegradation 1993, 4, 91–99. [Google Scholar] [CrossRef]
- Tsuchida, S.; Murata, K.; Ohkuma, M.; Ushida, K. Isolation of Streptococcus gallolyticus with very high degradability of condensed tannins from feces of the wild Japanese rock ptarmigans on Mt. Tateyama. J. Gen. Appl. Microbiol. 2017, 63, 195–198. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tsuchida, S.; Ohara, Y.; Kuramochi, K.; Murata, K.; Ushida, K. Effective degradation of phenolic glycoside rhododendron and its aglycone rhododendron by feces of wild Japanese rock ptarmigans. J. Zoo Wildl. Med. 2017, 22, 41–45. [Google Scholar] [CrossRef]
- Tsuchida, S.; Kitahara, M.; Nguema, P.P.M.; Norimitsu, S.; Fujita, S.; Yamagiwa, J.; Ngomanda, A.; Ohkuma, M.; Ushida, K. Lactobacillus gorillae sp. nov. isolated from the faeces of captive and wild western lowland gorillas (Gorilla gorilla gorilla). Int. J. Syst. Evol. Microbiol. 2014, 64, 4001–4006. [Google Scholar] [CrossRef] [PubMed]
- Tsuchida, S.; Takahashi, S.; Nguema, P.P.M.; Fujita, S.; Kitahara, M.; Yamagiwa, J.; Ngomanda, A.; Ohkuma, M.; Ushida, K. Bifidobacterium moukalabense sp. nov. isolated from the faeces of wild west lowland gorilla (Gorilla gorilla gorilla) in Gabon. Int. J. Syst. Evol. Microbiol. 2014, 64, 449–455. [Google Scholar] [CrossRef] [PubMed]
- Tsukahara, T.; Ushida, K. Succinate accumulation in pig large intestine during antibiotic-associated diarrhea and the constitution of succinate-producing flora. J. Gen. Appl. Microbiol. 2002, 48, 143–154. [Google Scholar] [CrossRef] [PubMed]
- Kumar, S.; Stecher, G.; Tamura, T. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 2016, 33, 1870–1874. [Google Scholar] [CrossRef] [PubMed]
- Thompson, J.D.; Higgins, D.G.; Gibson, T.J.; Clustal, W. Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22, 4673–4680. [Google Scholar] [CrossRef] [PubMed]
- Saitou, N.; Nei, M. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 1987, 4, 406–425. [Google Scholar] [PubMed]
- Kimura, M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 1980, 16, 111–120. [Google Scholar] [CrossRef] [PubMed]
- Onda, T.; Yanagida, F.; Tsuji, M.; Ogino, S.; Shinohara, T. Isolation and characterization of the Lactic acid bacterial strain GM005 producing a antibacterial substance from miso-paste product. Food Sci. Technol. Res. 1999, 5, 247–250. [Google Scholar] [CrossRef]
- Scally, A.; Dutheil, J.Y.; Hillier, L.W.; Jordan, G.E.; Goodhead, I.; Herrero, J.; Hobolth, A.; Lappalainen, T.; Mailund, T.; Marques-Bonet, T.; et al. Insight into hominid evolution from the gorilla genome sequence. Nature 2012, 483, 169–175. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Song, Y.; Kato, N.; Liu, C.; Matsumiya, Y.; Kato, H.; Watanabe, K. Rapid identification 11 human intestinal Lactobacillus species by multiplex PCR assays using group-and species-specific primers derived from the 16S–23S rRNA intergenic specer region and its flanking 23S rRNA. FEMS Microbiol. Lett. 2000, 187, 167–173. [Google Scholar] [CrossRef]
- Gaqneux, P.; Wills, C.; Gerloff, U.; Tautz, D.; Morin, P.A.; Boesch, C.; Fruth, B.; Hohmann, G.; Ryder, O.A.; Woodruff, D.S. Mitochondrial sequences show diverse evolutionaly histories of African hominoids. Proc. Natl. Acad. Sci. USA 1999, 96, 5077–5082. [Google Scholar] [CrossRef]
- Stewart, C.B.; Disotell, T.R. Primate evolution-in and out of Africa. Curr. Biol. 1998, 8, 582–588. [Google Scholar] [CrossRef]
- Kundaković, T.; Ćirić, A.; Stanojković, T.; Soković, M.; Kovačević, N. Cytotoxicity and antimicrobial activity of Pyrus pyraster Burgsd. and Pyrus spinosa Forssk (Rosaceae). Afr. J. Microbiol. Res. 2014, 8, 511–518. [Google Scholar]
- Jones, R.J.; Lowry, J.B. Australian goats detoxify the goitrogen 3-hydroxy-4(1H) pyridone (DHP) after rumen infusion from an Indonesian goat. Experientia 1984, 40, 1435–1436. [Google Scholar] [CrossRef] [PubMed]
- Iwata, Y.; Nakashima, Y.; Tsuchida, S.; Nguema, P.P.; Ando, C.; Ushida, K.; Yamagiwa, J. Decaying toxic wood as sodium supplement for herbivorous mammals in Gabon. J. Vet. Med. Sci. 2015, 77, 1247–1252. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Magliocca, F.; Gautier-Hion, A. Mineral content as a basis for food selection by western lowland gorillas in the Dzanga National Park, Central Africa Republic. J. Trop. Ecol. 1998, 14, 829–839. [Google Scholar]
- Tsuchida, S.; Nezuo, M.; Tsukahara, M.; Ogura, Y.; Hayashi, T.; Ushida, K. Draft genome sequence of Lactobacillus gorillae Strain KZ01T, isolated from a Western Lowland Gorilla. Genome Announc. 2015, 3, e01196-15. [Google Scholar] [CrossRef] [PubMed]
- Gueimonde, M.; Sanchez, B.G.; de Los Reyes-Gavilan, C.; Margolles, A. Antibiotic resistance in probiotic bacteria. Front. Microbiol. 2013, 4, 202. [Google Scholar] [CrossRef] [PubMed]
Figure 1.
Phylogenetic tree based on partial 16S rRNA gene sequences showing the relationships between L. gorillae and members of related Lactobacillus species. The tree was conducted by neighbor-joining method. L. delbruekii subsp. delbrueckii JCM 1012T was used as an out-group. Bootstrap values (>50%) based on 1000 replicates are shown at branch nodes. Bars represent 0.02 substitutions per nucleotide position.
Figure 1.
Phylogenetic tree based on partial 16S rRNA gene sequences showing the relationships between L. gorillae and members of related Lactobacillus species. The tree was conducted by neighbor-joining method. L. delbruekii subsp. delbrueckii JCM 1012T was used as an out-group. Bootstrap values (>50%) based on 1000 replicates are shown at branch nodes. Bars represent 0.02 substitutions per nucleotide position.
Figure 2.
Antimicrobial activities of strains from gorillas. MW—strains from wild mountain gorillas (n = 5); WW—strains from wild western lowland gorillas (n = 5); WC—strains from captive western lowland gorillas (n = 8). In the box plot, the line in the middle of the box represents the median; the upper and lower perimeters of the box represents the 75th and 25th centiles, respectively; and the tails represent 2.5th and 97.5th centiles, respectively. ** p < 0.01.
Figure 2.
Antimicrobial activities of strains from gorillas. MW—strains from wild mountain gorillas (n = 5); WW—strains from wild western lowland gorillas (n = 5); WC—strains from captive western lowland gorillas (n = 8). In the box plot, the line in the middle of the box represents the median; the upper and lower perimeters of the box represents the 75th and 25th centiles, respectively; and the tails represent 2.5th and 97.5th centiles, respectively. ** p < 0.01.
Table 1.
The strains of L. gorillae used in this study.
| Strain ID | Animal Species | Captive or Wild |
|---|---|---|
| KZ01T (JCM 19575T) | Western lowland gorilla | Captive |
| KZ02 (JCM 19576) | Western lowland gorilla | Captive |
| KZ03 (JCM 19577) | Western lowland gorilla | Captive |
| HZ04 | Western lowland gorilla | Captive |
| HZ07 | Western lowland gorilla | Captive |
| HZ10 | Western lowland gorilla | Captive |
| HZ11 | Western lowland gorilla | Captive |
| HZ16 | Western lowland gorilla | Captive |
| GG02 (JCM 19574) | Western lowland gorilla | Wild |
| GG05 | Western lowland gorilla | Wild |
| GG08 | Western lowland gorilla | Wild |
| GG12 | Western lowland gorilla | Wild |
| GG15 | Western lowland gorilla | Wild |
| UM01 | Mountain gorilla | Wild |
| UM03 | Mountain gorilla | Wild |
| UR07 | Mountain gorilla | Wild |
| UR10 | Mountain gorilla | Wild |
| UH14 | Mountain gorilla | Wild |
Table 2.
Differential phenotypic characteristics of the strains of L. gorillae.
| Animal Species | Western Lowland Gorilla | Mountain Gorilla | Prevalent in Human | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Isolated from | Captive Individuals | Wild Individuals | Fermented Food | ||||||||||||||||
| Characteristic | KZ01T | KZ02 | KZ03 | HZ04 | HZ07 | HZ10 | HZ11 | HZ16 | GG02 | GG05 | GG08 | GG12 | GG15 | UM01 | UM03 | UR07 | UR10 | UH14 | L. fermentum JCM 1173T |
| Acid production from (API 50CH): | |||||||||||||||||||
| D-xylose | − | − | + | − | − | + | + | + | + | + | + | + | + | + | + | + | + | + | − |
| Arbutin | − | − | w | − | − | w | − | + | w | w | w | w | w | + | w | w | + | w | − |
| Esculin | + | − | + | + | + | + | + | + | + | + | + | + | + | w | + | + | + | w | − |
| Salicin | − | − | − | − | − | − | − | − | w | w | w | w | w | + | + | w | + | + | − |
| Cellobiose | − | − | w | − | w | w | - | + | w | w | w | w | w | + | + | + | + | + | − |
| Lactose | − | − | + | − | − | + | - | + | w | w | w | + | w | + | + | + | + | + | + |
| Trehalose | − | − | + | − | − | + | - | + | + | + | + | + | + | + | + | + | + | + | − |
| Gluconate | − | − | + | − | − | w | - | w | w | w | w | w | + | + | + | + | + | + | w |
| 2-keto-gluconate | − | − | − | − | − | - | - | - | - | - | - | - | - | + | + | + | + | + | − |
| API ZYM results: | |||||||||||||||||||
| Cystine arylamidase | − | − | − | − | − | − | − | − | − | − | − | − | − | + | + | + | + | + | + |
| Naphthol-AS-BI-phosphohydrolase | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | + |
| α-galactosidase | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | − |
| α-glucosidase | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | + |
| Growth in Nacl | |||||||||||||||||||
| 6.5% | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | − |
| 8% | + | + | + | + | + | + | + | + | − | − | − | − | − | − | − | − | − | − | − |
+: positive, −: negative, W: weak.
Table 3.
Antibiotic resistant profile of the strains of L. gorillae.
| Animal Species | Western Lowland Gorilla | Mountain Gorilla | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Isolated from | Captive Individuals | Wild Individuals | ||||||||||||||||
| Characteristic | KZ01T | KZ02 | KZ03 | HZ04 | HZ07 | HZ10 | HZ11 | HZ16 | GG02 | GG05 | GG08 | GG12 | GG15 | UM01 | UM03 | UR07 | UR10 | UH14 |
| Antibiotics: | ||||||||||||||||||
| Imipenem (10 µg/disk) | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| Cefotaxime (30 µg/disk) | I | R | S | I | I | I | R | S | S | S | S | S | S | S | S | S | S | S |
| Ofloxacin (5 µg/disk) | R | R | R | R | R | R | R | R | S | S | S | S | S | R | R | R | R | R |
| Amoxicillin (25 µg/disk) | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| Gentamicin (10 µg/disk) | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| Lincomycin (2 µg/disk) | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| Tetracycline (30 µg/disk) | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| Erythromycin (15 µg/disk) | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
S: sensitive, I: Intermediate, R: resistant.
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Tsuchida, S.; Kakooza, S.; Mbehang Nguema, P.P.; Wampande, E.M.; Ushida, K. Characteristics of Gorilla-Specific Lactobacillus Isolated from Captive and Wild Gorillas. Microorganisms 2018, 6, 86. https://doi.org/10.3390/microorganisms6030086
AMA Style
Tsuchida S, Kakooza S, Mbehang Nguema PP, Wampande EM, Ushida K. Characteristics of Gorilla-Specific Lactobacillus Isolated from Captive and Wild Gorillas. Microorganisms. 2018; 6(3):86. https://doi.org/10.3390/microorganisms6030086
Chicago/Turabian StyleTsuchida, Sayaka, Steven Kakooza, Pierre Philippe Mbehang Nguema, Eddie M. Wampande, and Kazunari Ushida. 2018. "Characteristics of Gorilla-Specific Lactobacillus Isolated from Captive and Wild Gorillas" Microorganisms 6, no. 3: 86. https://doi.org/10.3390/microorganisms6030086
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
